Targeting Tumor Angiogenesis with Gene Therapy

Molecular Genetics and Metabolism - Tập 74 - Trang 120-127 - 2001
Qing-Rong Chen1, Lei Zhang1, Warren Gasper1, A.James Mixson1
1Department of Pathology, University of Maryland at Baltimore, Baltimore, Maryland, 21201

Tài liệu tham khảo

Jaffe, 1987, Cell biology of endothelial cells, Hum Pathol, 18, 234, 10.1016/S0046-8177(87)80005-9 Denekamp, 1993, Review article: Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy, Br J Radiol, 66, 181, 10.1259/0007-1285-66-783-181 Folkman, 1971, Tumor angiogenesis: Therapeutic implications, N Eng J Med, 333, 1757, 10.1056/NEJM199512283332608 Folkman, 1976, The vasculization of tumors, Sci Am, 234, 58, 10.1038/scientificamerican0576-58 Folkman, 1998, Antiangiogenic gene therapy, Proc Natl Acad Sci USA, 95, 9064, 10.1073/pnas.95.16.9064 O'Reilly, 1996, Angiostatin induces and sustains dormancy of human primary tumors in mice, Nature Med, 2, 689, 10.1038/nm0696-689 O'Reilly, 1997, Endostatin: An endogenous inhibitor of angiogenesis and tumor growth, Cell, 88, 277, 10.1016/S0092-8674(00)81848-6 Kerbel, 1991, Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anticancer therapeutic agents, Bioessays, 13, 31, 10.1002/bies.950130106 Boehm, 1997, Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance, Nature, 390, 404, 10.1038/37126 Millauer, 1994, Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant, Nature, 367, 576, 10.1038/367576a0 Saleh, 1996, Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence, Cancer Res, 56, 383 Lin, 1998, Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2, Proc Natl Acad Sci USA, 95, 8829, 10.1073/pnas.95.15.8829 Goldman, 1998, Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate, Proc Natl Acad Sci USA, 95, 8795, 10.1073/pnas.95.15.8795 Griscelli, 1998, Soria C, Perricaudet M, Yeh P, Lu H, Proc Natl Acad Sci USA, 95, 6367, 10.1073/pnas.95.11.6367 Chen, 1999, Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice, Cancer Res, 59, 3308 Blezinger, 1999, Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene, Nature Biotechnol, 17, 623, 10.1038/7895 Machein, 1999, Antiangiogenic gene therapy in a rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2, Hum Gene Ther, 10, 1117, 10.1089/10430349950018111 Sasaki, 1999, Retrovirus producer cells encoding antisense VEGF prolong survival of rats with intracranial GS9L gliomas, Int J Dev Neurosci, 17, 579, 10.1016/S0736-5748(99)00053-2 Grant, 1999, Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells, Circ Res, 85, 699, 10.1161/01.RES.85.8.699 Weng, 2001, Angiozyme: A novel angiogenesis inhibitor, Curr Oncol Rep, 3, 141, 10.1007/s11912-001-0014-7 Tanaka, 1997, Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth, Nature Med, 3, 437, 10.1038/nm0497-437 Gengrinovitch, 1995, Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms, J Biol Chem, 270, 15059, 10.1074/jbc.270.25.15059 Boggio, 2000, Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice, Cancer Res, 60, 359 Sharpe, 1990, Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4, J Natl Cancer Inst, 82, 848, 10.1093/jnci/82.10.848 Voest, 1995, Inhibition of angiogenesis in vivo by interleukin 12, J Natl Cancer Inst, 87, 581, 10.1093/jnci/87.8.581 Sgadari, 1996, Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10, Blood, 87, 3877, 10.1182/blood.V87.9.3877.bloodjournal8793877 Angiolillo, 1996, A role for the interferon-inducible protein 10 in inhibition of angiogenesis by interleukin-12, Ann N Y Acad Sci, 795, 158, 10.1111/j.1749-6632.1996.tb52664.x Blezinger, 1999, Intratracheal administration of interleukin 12 plasmid-cationic lipid complexes inhibits murine lung metastases, Hum Gene Ther, 10, 723, 10.1089/10430349950018481 Yao, 1999, Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12, Blood, 93, 1612, 10.1182/blood.V93.5.1612 MacDonald, N, J, Shivers, W, Y, Plum, S, M, Sim, B, KL, Endostatin proteins binds tropomyosin: Potential for modulation of the anti-angiogenic activity of Endostatin protein. Presentations at the American Association of Cancer Research Conference on Molecular Targets and Cancer Therapeutics, 1999. Moser, 1999, Angiostatin binds ATP synthase on the surface of human endothelial cells, Proc Natl Acad Sci USA, 96, 2811, 10.1073/pnas.96.6.2811 Cao, 1998, Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases, J Clin Invest, 101, 1055, 10.1172/JCI1558 Liu, 1999, Systemic gene delivery expands the repertoire of effective antiangiogenic agents, J Biol Chem, 274, 13338, 10.1074/jbc.274.19.13338 Ding, 2001, Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas, Cancer Res, 61, 526 Feldman, 2000, Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice, Cancer Res, 60, 1503 Regulier, 2001, Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach, Cancer Gene Ther, 8, 45, 10.1038/sj.cgt.7700278 Sauter, 2000, Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases, Proc Natl Acad Sci USA, 97, 4802, 10.1073/pnas.090065597 Wen, 2001, Adenovirus-mediated human endostatin gene delivery demonstrates strain-specific antitumor activity and acute dose-dependent toxicity in mice, Hum Gene Ther, 12, 347, 10.1089/10430340150503975 Thurston, 1998, Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice, J Clin Invest, 101, 1410, 10.1172/JCI965 Arap, 1998, Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model, Science, 279, 377, 10.1126/science.279.5349.377 Pasqualini, 1997, Alpha v integrins as receptors for tumor targeting by circulating ligands, Nature Biotechnol, 15, 542, 10.1038/nbt0697-542 Matsuda, 2000, A novel strategy for the tumor angiogenesis-targeted gene therapy: Generation of angiostatin from endogenous plasminogen by protease gene transfer, Cancer Gene Ther, 7, 589, 10.1038/sj.cgt.7700147 Roth, 1996, Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer, Nature Med, 2, 985, 10.1038/nm0996-985 Xu, 1996, Parenteral Gene Therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity, Hum Gene Ther, 8, 177, 10.1089/hum.1997.8.2-177 Bouvet, 1998, Adenovirus- mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer, Cancer Res, 58, 2288 Riccioni, 1998, Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo, Gene Therapy, 5, 747, 10.1038/sj.gt.3300681 Lesoon-Wood, 1995, Systemic gene therapy with p53 reduces growth and metastases of a maligangt human breast cancer in nude mice, Hum Gene Ther, 6, 395, 10.1089/hum.1995.6.4-395 Hsiao, 1997, Intracavitary liposome-mediated p53 gene transfer into glioblastoma with endogenous wild-type p53 in vivo results in tumor suppression and long-term survival, Biochem Biophys Res Commun, 233, 359, 10.1006/bbrc.1997.6459 Xu, 1999, Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts, Hum Gene Ther, 10, 2941, 10.1089/10430349950016357 Folkman, 1997, 3075 Dameron, 1994, Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1, Science, 265, 1582, 10.1126/science.7521539 Zabrenetzky, 1994, Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung, and breast carcinoma, Int J Cancer, 59, 191, 10.1002/ijc.2910590209 Tolsma, 1993, Peptides derived from two separate domains of the matrix protein thrombospondin I have anti-angiogenic activity, J Cell Biol, 122, 497, 10.1083/jcb.122.2.497 Guo, 1997, Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1, J Pept Res, 50, 210, 10.1111/j.1399-3011.1997.tb01187.x Weinstat-Saslow, 1994, Transfection of thrombospondin I complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis, Cancer Res, 54, 6504 Xu, 1998, Gene therapy with p53 and a fragment of thrombospondin I inhibits human breast cancer in vivo, Mol Genet Metab, 63, 103, 10.1006/mgme.1997.2654 Streit, 1999, Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis, Proc Natl Acad Sci USA, 96, 14888, 10.1073/pnas.96.26.14888 Baker, 1999, Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3, Br J Cancer, 79, 1347, 10.1038/sj.bjc.6690217 Valente, 1998, TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis, Int J Cancer, 75, 246, 10.1002/(SICI)1097-0215(19980119)75:2<246::AID-IJC13>3.0.CO;2-B Cao, 1997, Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth, J Biol Chem, 272, 22924, 10.1074/jbc.272.36.22924 Cao, 1999, Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis, Proc Natl Acad Sci USA, 96, 5728, 10.1073/pnas.96.10.5728 Lu, 1999, Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells, Biochem Biophys Res Commun, 258, 668, 10.1006/bbrc.1999.0612 Wei, 2000, Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine, Nature Med, 6, 1160, 10.1038/80506 St Croix, 2000, Genes expressed in human tumor endothelium, Science, 289, 1197, 10.1126/science.289.5482.1197